Equities

ECO Animal Health Group PLC

EAH:LSE

ECO Animal Health Group PLC

Health CarePharmaceuticals and Biotechnology
  • Price (GBX)107.50
  • Today's Change5.00 / 4.88%
  • Shares traded82.75k
  • 1 Year change-8.51%
  • Beta0.4228
Data delayed at least 20 minutes, as of Apr 26 2024 16:38 BST.
More ▼

Financials data is unavailable for this security.

Inc stmt in GBPIncome statement in GBPView more

Year on year ECO Animal Health Group PLC grew revenues 3.79% from 82.20m to 85.31m while net income improved from a loss of 686.00k to a gain of 1.01m.
Gross margin43.05%
Net profit margin-0.25%
Operating margin1.45%
Return on assets-0.19%
Return on equity-1.97%
Return on investment-0.26%
More ▼

Cash flow in GBPView more

In 2023, ECO Animal Health Group PLC increased its cash reserves by 51.31%, or 7.34m. The company earned 15.91m from its operations for a Cash Flow Margin of 18.64%. In addition the company used 5.88m on investing activities and also paid 2.40m in financing cash flows.
Cash flow per share0.0357
Price/Cash flow per share30.22
Book value per share1.20
Tangible book value per share0.6627
More ▼

Balance sheet in GBPView more

ECO Animal Health Group PLC uses little debt in its capital structure as supported by a debt to capital ratio of 4.37%.
Current ratio3.16
Quick ratio2.26
Total debt/total equity0.0508
Total debt/total capital0.0437
More ▼

Growth rates in GBP

Year on year, growth in earnings per share excluding extraordinary items increased 245.01%. Additionally, five year annualized earnings per share growth is in-line with the industry average relative to its peers.
Div yield(5 year avg)0.56%
Div growth rate (5 year)--
Payout ratio (TTM)--
EPS growth(5 years)-36.35
EPS (TTM) vs
TTM 1 year ago		-310.61
More ▼
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.